UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic significance of microsatellite‐instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy

International journal of cancer, 2019-04, Vol.144 (7), p.1697-1703

2019

Volltextzugriff (PDF)

Patient expectations are better for immunotherapy than traditional chemotherapy for cancer

Journal of cancer research and clinical oncology, 2020-12, Vol.146 (12), p.3189-3198

2020

Volltextzugriff (PDF)

Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.49 (1), p.54-63

2021

Volltextzugriff (PDF)

The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients

BMC cancer, 2020-06, Vol.20 (1), p.529-529, Article 529

2020

Volltextzugriff (PDF)

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)

Cancers, 2021-04, Vol.13 (8), p.1936

2021

Volltextzugriff (PDF)

Diagnostik von neuroendokrinen Neoplasien am Beispiel der GEP-NEN

InFo Hämatologie + Onkologie, 2023-12, Vol.26 (12), p.8-11

2023

Volltextzugriff (PDF)

Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy

PloS one, 2017-08, Vol.12 (8), p.e0183845-e0183845

2017

Volltextzugriff (PDF)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial

BMC cancer, 2021-11, Vol.21 (1), p.1206-9, Article 1206

2021

Volltextzugriff (PDF)

Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms

Biology (Basel, Switzerland), 2021-03, Vol.10 (4), p.277

2021

Volltextzugriff (PDF)

Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease

Frontiers in endocrinology (Lausanne), 2021-10, Vol.12, p.709256-709256

2021

Volltextzugriff (PDF)

Use of antiresorptive therapy (ART) and skeletal-related events (SREs) in patients with bone metastases of neuroendocrine neoplasms (NEN)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4096-4096

2017

Volltextzugriff (PDF)

Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial

European journal of cancer (1990), 2022-05, Vol.167, p.112-122

2022

Volltextzugriff (PDF)

Efficacy and toxicity of topotecan in pretreated metastatic extrapulmonary neuroendocrine carcinoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15194-e15194

2015

Volltextzugriff (PDF)

Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (16), p.14785-14796

2023

Volltextzugriff (PDF)

Multicenter analysis of treatment outcomes for well differentiated grade 3 neuroendocrine tumors (NET G3)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4607-4607

2020

Volltextzugriff (PDF)

Treatment outcomes of patients with mixed neuroendocrine-nonneuroendocrine neoplasms (MiNEN)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16163-e16163

2018

Volltextzugriff (PDF)

Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment

Journal of cancer research and clinical oncology, 2023-04, Vol.149 (4), p.1373-1382

2023

Volltextzugriff (PDF)

Treatment outcomes of patients with mixed adenoneuroendocrine carcinoma (MANEC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15187-e15187

2015

Volltextzugriff (PDF)

Financial toxicity in patients with colorectal cancer and neuroendocrine tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6533-6533

2018

Volltextzugriff (PDF)

A phase II, open label, multicenter trial of avelumab in patients with advanced, metastatic high-grade neuroendocrine carcinomas NEC G3 (WHO 2010) progressive after first-line chemotherapy (AVENEC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4103-4103

2019

Volltextzugriff (PDF)

Combined PD-1 inhibition (Pembrolizumab) and CCR5 inhibition (Maraviroc) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): First results of the PICCASSO phase I trial

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3010-3010

2020

Volltextzugriff (PDF)

Morphological correlates of oxaliplatin induced peripheral neuropathy assessed by magnetic resonance neurography

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.10092-10092

2017

Volltextzugriff (PDF)

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate

Oncotarget, 2019-01, Vol.10 (1), p.17-29

2019

Volltextzugriff (PDF)

Gene expression-based prediction of pazopanib efficacy in sarcoma

European journal of cancer (1990), 2022-09, Vol.172, p.107-118

2022

Volltextzugriff (PDF)

Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma

Cancer medicine (Malden, MA), 2016-09, Vol.5 (9), p.2261-2267

2016

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Oncology
(20)
Humans
(17)
Patients
(14)
Chemotherapy
(13)
Male
(11)
Middle Aged
(11)
Aged
(9)
Metastasis
(9)
Adult
(8)
Cancer
(8)
Female
(8)
Metastases
(8)
Tumors
(7)
Cancer Therapies
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Medical Research
(5)
Medicine
(5)
Medicine & Public Health
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic significance of microsatellite‐instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy

Patient expectations are better for immunotherapy than traditional chemotherapy for cancer

Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)

Diagnostik von neuroendokrinen Neoplasien am Beispiel der GEP-NEN

Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial

Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms

Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease

Use of antiresorptive therapy (ART) and skeletal-related events (SREs) in patients with bone metastases of neuroendocrine neoplasms (NEN)

Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial

Efficacy and toxicity of topotecan in pretreated metastatic extrapulmonary neuroendocrine carcinoma

Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up

Multicenter analysis of treatment outcomes for well differentiated grade 3 neuroendocrine tumors (NET G3)

Treatment outcomes of patients with mixed neuroendocrine-nonneuroendocrine neoplasms (MiNEN)

Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment

Treatment outcomes of patients with mixed adenoneuroendocrine carcinoma (MANEC)

Financial toxicity in patients with colorectal cancer and neuroendocrine tumors

A phase II, open label, multicenter trial of avelumab in patients with advanced, metastatic high-grade neuroendocrine carcinomas NEC G3 (WHO 2010) progressive after first-line chemotherapy (AVENEC)

Combined PD-1 inhibition (Pembrolizumab) and CCR5 inhibition (Maraviroc) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): First results of the PICCASSO phase I trial

Morphological correlates of oxaliplatin induced peripheral neuropathy assessed by magnetic resonance neurography

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate

Gene expression-based prediction of pazopanib efficacy in sarcoma

Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma

Suchergebnisse filtern